These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 17009908)
41. Blood biomarkers for prostate cancer detection and prognosis. Shariat SF; Karam JA; Roehrborn CG Future Oncol; 2007 Aug; 3(4):449-61. PubMed ID: 17661720 [TBL] [Abstract][Full Text] [Related]
42. Protein chips and nanomaterials for application in tumor marker immunoassays. Chen H; Jiang C; Yu C; Zhang S; Liu B; Kong J Biosens Bioelectron; 2009 Aug; 24(12):3399-411. PubMed ID: 19398322 [TBL] [Abstract][Full Text] [Related]
43. [Hapten immunoassays: current status and future prospect]. Kobayashi N Rinsho Byori; 2008 Jun; 56(6):525-35. PubMed ID: 18646638 [TBL] [Abstract][Full Text] [Related]
44. Diagnostics for a personalized medical future: extending our senses to the molecular scale. Miller BL Stud Health Technol Inform; 2009; 149():297-310. PubMed ID: 19745489 [TBL] [Abstract][Full Text] [Related]
45. Microfluidic systems integrated with two-dimensional surface plasmon resonance phase imaging systems for microarray immunoassay. Lee KH; Su YD; Chen SJ; Tseng FG; Lee GB Biosens Bioelectron; 2007 Nov; 23(4):466-72. PubMed ID: 17618110 [TBL] [Abstract][Full Text] [Related]
46. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Melanson SE; Morrow DA; Jarolim P Am J Clin Pathol; 2007 Aug; 128(2):282-6. PubMed ID: 17638663 [TBL] [Abstract][Full Text] [Related]
47. Dendrimers and their applications in immunoassays and clinical diagnostics. Singh P Biotechnol Appl Biochem; 2007 Sep; 48(Pt 1):1-9. PubMed ID: 17688425 [TBL] [Abstract][Full Text] [Related]
48. Reverse-phase versus sandwich antibody microarray, technical comparison from a clinical perspective. Järås K; Ressine A; Nilsson E; Malm J; Marko-Varga G; Lilja H; Laurell T Anal Chem; 2007 Aug; 79(15):5817-25. PubMed ID: 17605470 [TBL] [Abstract][Full Text] [Related]
49. In vitro diagnostic prospects of nanoparticles. Azzazy HM; Mansour MM Clin Chim Acta; 2009 May; 403(1-2):1-8. PubMed ID: 19361470 [TBL] [Abstract][Full Text] [Related]
50. Development of sensitive immunoassays for the detection of the glucuronide conjugate of 3-phenoxybenzyl alcohol, a putative human urinary biomarker for pyrethroid exposure. Kim HJ; Ahn KC; Ma SJ; Gee SJ; Hammock BD J Agric Food Chem; 2007 May; 55(10):3750-7. PubMed ID: 17455946 [TBL] [Abstract][Full Text] [Related]
51. Evaluation of immunoturbidimetric specific protein methods using the Architect ci8200: comparison with immunonephelometry. Denham E; Mohn B; Tucker L; Lun A; Cleave P; Boswell DR Ann Clin Biochem; 2007 Nov; 44(Pt 6):529-36. PubMed ID: 17961307 [TBL] [Abstract][Full Text] [Related]
52. Nanoparticle-based Point of Care Immunoassays for in vitro Biomedical Diagnostics. Nishat S; Awan FR; Bajwa SZ Anal Sci; 2019 Feb; 35(2):123-131. PubMed ID: 30224569 [TBL] [Abstract][Full Text] [Related]
53. Advances in malaria diagnosis. Hawkes M; Kain KC Expert Rev Anti Infect Ther; 2007 Jun; 5(3):485-95. PubMed ID: 17547512 [TBL] [Abstract][Full Text] [Related]
54. Insights in the application of research-grade diagnostic kits for biomarker assessments in support of clinical drug development: bioanalysis of circulating concentrations of soluble receptor activator of nuclear factor kappaB ligand. Bowsher RR; Sailstad JM J Pharm Biomed Anal; 2008 Dec; 48(5):1282-9. PubMed ID: 18977625 [TBL] [Abstract][Full Text] [Related]
55. Method validation of protein biomarkers in support of drug development or clinical diagnosis/prognosis. Lee JW; Hall M J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1259-71. PubMed ID: 19038585 [TBL] [Abstract][Full Text] [Related]
56. The Simoa HD-1 Analyzer: A Novel Fully Automated Digital Immunoassay Analyzer with Single-Molecule Sensitivity and Multiplexing. Wilson DH; Rissin DM; Kan CW; Fournier DR; Piech T; Campbell TG; Meyer RE; Fishburn MW; Cabrera C; Patel PP; Frew E; Chen Y; Chang L; Ferrell EP; von Einem V; McGuigan W; Reinhardt M; Sayer H; Vielsack C; Duffy DC J Lab Autom; 2016 Aug; 21(4):533-47. PubMed ID: 26077162 [TBL] [Abstract][Full Text] [Related]
57. β-D-glucosidase assisted gold dissolution as non-optical and quantifiable detection technique for immunoassays. Koehler FM; Raso RA; Grass RN; Stark WJ Small; 2013 Dec; 9(23):4000-5. PubMed ID: 23670861 [TBL] [Abstract][Full Text] [Related]
58. Time-resolved fluorometer for lanthanide chelates--a new generation of nonisotopic immunoassays. Soini E; Kojola H Clin Chem; 1983 Jan; 29(1):65-8. PubMed ID: 6336682 [TBL] [Abstract][Full Text] [Related]